Pet DNA Testing Market to Reach $960.7 Million, Globally, by 2034 at 9.3% CAGR

According to the report, the pet DNA testing market was valued at $394.1 million in 2024, and is estimated to reach $960.7 million by 2034, growing at a CAGR of 9.3% from 2025 to 2034.

Request Sample of the Report on Global Pet DNA Testing Market 2034 - https://www.alliedmarketresearch.com/request-sample/A325828

Market Introduction

The pet DNA testing market encompasses genetic testing kits and services designed to analyze the DNA of companion animals primarily dogs and cats for insights into breed composition, hereditary traits, and potential health risks. These tests utilize saliva or blood samples to decode the animal's genetic makeup, offering valuable information that supports personalized pet care, breed validation, and preventive veterinary treatment. Pet DNA testing is increasingly used by pet owners, breeders, and veterinarians across home, clinical, and research settings. The market has gained global momentum due to the rising trend of pet humanization, growing pet adoption rates, and increasing awareness of genomics in animal health. According to the American Pet Products Association (APPA), pet ownership in the U.S. reached over 66% of households in 2023, reflecting a robust consumer base for personalized pet services.

In addition, the increasing prevalence of breed-specific conditions and the demand for tailored nutrition and training have reinforced the need for genetic insights. Direct-to-consumer (DTC) models and digital platforms have made test kits more accessible and user-friendly, contributing to the market's expansion. Manufacturers are also enhancing test accuracy, reporting interfaces, and panel diversity covering ancestry, allergies, and behavioral traits. Regulatory attention in regions like North America and Europe is promoting responsible marketing and data privacy compliance in genetic testing services. Emerging economies in Asia-Pacific and Latin America offer untapped potential due to rising disposable incomes, urbanization, and growing awareness of pet wellness. Overall, the pet DNA testing market continues to evolve rapidly, supported by technological advancements, evolving consumer expectations, and the broader shift toward precision and preventive care in veterinary medicine.

Report Overview:

The pet DNA testing market is segmented into animal type, sample type, test type, end user, and region. On the basis of animal type, it is bifurcated into dogs, cats and others. On the basis of sample type, the market is segregated into manual saliva, blood, and others. On the basis of test type, the market is categorized into breed profile, genetic disease, and others. On the basis of end user, the market is categorized into breeders, pet owners, and veterinarians. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

On the basis of animal type, the dogs segment dominated the market in terms of revenue in 2024. However, the cats segment is anticipated to grow at the fastest CAGR during the forecast period.

On the basis of sample type, the saliva segment dominated the market in terms of revenue in 2024 and is anticipated to grow at the fastest CAGR during the forecast period.

On the basis of test type, the breed profile segment dominated the market in terms of revenue in 2024. However, the genetic disease segment is anticipated to grow at the fastest CAGR during the forecast period.

On the basis of end user, the breeders segment dominated the market in terms of revenue in 2024. However, the pet owners segment is anticipated to grow at the fastest CAGR during the forecast period.

Region-wise, North America generated the largest revenue in 2024. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A325828

Market Growth & Opportunities Factors:

The pet DNA testing market is witnessing robust growth, fueled by rising pet adoption rates, increasing spending on companion animal healthcare, and growing awareness about the benefits of genetic testing. As pet owners focus on the well-being of their animals, there is growing demand for tools that provide insights into breed composition, inherited diseases, behavioral traits, and wellness predispositions. Pet DNA tests are now widely used for preventive health management, personalized nutrition planning, and breed authentication particularly among dogs and cats. This shift toward proactive, personalized pet care is a major factor driving the adoption of DNA testing kits and services.

Major Challenges in Industry & Solutions:

Despite strong market momentum, the pet DNA testing industry faces several challenges. One of the foremost is lack of standardization and regulatory oversight. Unlike human genetic testing, pet DNA testing operates with limited regulatory control, leading to variability in test accuracy, interpretation, and consumer claims. This can undermine customer trust and lead to inconsistent outcomes. To address this, industry players are voluntarily adopting quality assurance protocols and seeking partnerships with veterinary professionals to ensure reliable and clinically actionable results. Third-party certifications and transparent reporting formats are also gaining traction as credibility becomes a competitive differentiator.

Another challenge is the limited genetic databases for certain breeds or species, particularly in cats and mixed-breed animals. Incomplete reference panels may affect the accuracy of breed or trait identification, especially for less common breeds. Companies are mitigating this by continuously expanding their genomic datasets through ongoing sample collection and collaboration with breed clubs, veterinary schools, and pet registries.

Cost is a constraint in some regions. While prices have declined with scale, premium DNA test kits can still be expensive for average pet owners in price-sensitive markets. To overcome this, companies are offering tiered pricing models, including basic ancestry tests at lower costs and more advanced health panels at premium rates. Additionally, retail partnerships with pet stores and online platforms are helping to drive awareness and improve affordability.

For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A325828

Regional Insights

North America holds the largest share of the pet DNA testing market, driven by high pet ownership, increasing demand for pet wellness services, and strong veterinary infrastructure. The U.S. is a key contributor due to high awareness and the presence of major players like Embark and Wisdom Panel. Favorable consumer attitudes toward pet humanization, coupled with advanced e-commerce networks, support the dominance of this region. Integration with veterinary channels and pet insurance providers is also contributing to increased adoption.

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of 'Market Research Reports' and 'Business Intelligence Solutions'. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.